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Since the availability of the active hepatitis B vaccine in additiob to hepatitis B immunoglobulin it became possible to effectively interrr ~p t the potential transmission of virus from a pregnant carrier mother to her newborn. All babies (n.42) of HBsRg carrier mothers delivering at the munich University's women hospital and several city hospitals in Bavaria between october 1982 and december 1983 were given passive immunisation with 1 ml hepatitis B immunoglobulin and simultaneous active vaccination with 1 ml o f the hepatitis B vaccine (containing 20 pg HBsRg in 1 ml; ~-8-Vax(~)). Since january 1984 half the previous+ ly recommended dosis (10 p g HBsAg) has been administered to a further 35 infants. Finally with the beginning of this year some newborns at these hospitals will receive 5 pg HBsAg of the recombinant yeast-vaccine (NSD laboratories). Infants'serum samples were collected at birth, at the 2nd and 6th months of age (when the publicly recommended routine :heck-ups take place), and at the end of the first and second year of life. Results: All vaccinated newborns developed protecting antibody levels at a time when passively transferred anti-HBs has usually disappeared. The mean antibody-titer in the 20 pg group at the time of the third booster was higher than in the 10 pg group, but not significantly so. The new recombinant vaccine has been administered to 2 newborns a s yet and their antibody response remains to be seen. Since the 2.5 years of the study anti-HBs fell below the protective level of 10 mIU/ ml in two children only. These data suggest that a vaccine dosis of 10 pg HBsAg might be a s effective a s the previously used 20 pg dosis in most children. VACCINE ASSOCIATED POLIOMYELITIS. A 3 month old girl who developed paralytic poliomyelitis three weeks after the first oral dose of Sabin polio vaccine is described. After a three days episode of viral meningitis the child developed subsequently a quadriplegic form of poliomyelitis with facial nerve involvement. All three types of vaccine polio virus were isolated from the stool for a two month period. The child developed high antibody titers to all three types of poliovirus. The pathophysiology epidemology laboratory problems as well as preventive measures in case of vaccine associated poliomyelitis are presented. 1. The efficacy of a single antiviral drug Vira-A, Acyclovir, Beta lnterferon native and recombinant as cornpalred to a combination of two antiviral drugs acyclovir and Beta lnterferon was evaluated in experimental herpes keratitis In rabbits. As a single antlviral drug acyclovir ointment promoted the most rapid epitelization tlme, but during the treatment period virus 'escapes' were detected. The best results were obtianed with a combination of Beta lnterferon and acyclo vir demonstrating the potentiation of the antiviral activity of acyclovir by Beta Interferon. 2. In human herpes keratitis the combination of Beta interferon and acyclovir resulted in a rapid epitelization time, short virus shedding time and no relapse during a subsequent I8 month observation period. 3. in human herpes labialis the combination of Beta lnterferon and acyclovir resulted in a shortening of the disease to a 1/3 of the usual period. Prophylactic Beta lnterferon ointment when only numbling was felt prevented the appearance of vesicles on the lips. 4. In Herpes Zoster when started early in the disease the combination of acyclovir and Beta lnterferon resulted in a shortening of disease and rapid dissappearance of pain.
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During 1% nine of tk 135 patients (pts) adrrritted to our NICU had 11 epkdes of septi cmria with Staph epi.In the last 5 years we had 5. It is known that catheters in the upper digestive tract may alter the local flora. Therefore, we carried out bacterial counts on 165 gastric aspirates of neonates with gastrostomy and on 101 of neonates with feeding tubes. In the first group, organisms were found in 70 %, in the second group in 3 0 % of all cases. Enterobacteriaceae, Enterococci, Pseudomonas aeruginosa and Candida albicans were isolated far more frequently in the first group than in the second (pd0,Ol). 6 infants with gastrostomy developed septicaemia caused by the same organisms that were also found in high numbers in the gastric aspirates. The influence of non-absorbable antibiotics in children with gastrostomy was studied prospectively in 7 2 gastric aspirates and 48 specimens of stool. There was no highly significant difference between infants with antibiotic treatment versus those without. It is concluded that gastrostomy influences the flora of the stomach and may conceivably lead to a septicaemia.
Incidence of P-fimbriated E.coli in feces among children 185 leaving neonatal wards in Sweden.
Kjell Tullus, Lars Burman, Gunilla Kallenius and Stefan B Svenson Pediatric Clinic, Oanderyd Hospital and National Bacteriological Department, Sweden
We have previously shown that one P-flmbriated E.coli clone was spread in a neonatal ward. It could there c o l o n i z e c a l l y many of the children and also members of the staff. The children that were fecally colonized with the pyelonephritogenic, P-fimbriated E.coli clone ran a greater risk to develop pyelonephritis later on. We have therefore studied all children leaving twenty-two different neonatal wards after the age of five days. From each child we characterized five fecal strains. We found that a very high proportion (76%) had klebsiella/enterobacter in their feces when they left the ward. In only 395 of all the children we found E.coli in the feces. In most of t h a s a few children leaving the ward had P-fimbriated E.coli in the stool. Two of the wards showed periods of time when -many of the children leavlng the ward were colonized with a P-fimbriated E.coli strain.
We now continue to study these two clinics both prospectively and retrospectively to see if this relatively high incidence of P-fimbriated E.coli among the chlldren will lead to a higher incidence of pyelonephritis.
